Viktor Kharitonin Net Worth

Viktor Kharitonin has an estimated net worth of $7.9 billion, according to Forbes Real-Time Billionaires, Viktor Kharitonin profile (figures as of October 20, 2026). That is up from $1.2 billion in 2019.

Viktor Kharitonin is a Russian businessperson best known for building wealth in pharmaceuticals. He got his start selling consumer goods after graduating from Novosibirsk State University. In 2003, he helped create Pharmstandard with Roman Abramovich and other partners by combining 5 factories. That move gave him a strong position in healthcare and set up the company that became the main source of his fortune for years afterward.

Pharmstandard grew into a major asset after its London listing, and Kharitonin later increased control of the business. In 2008, he and Egor Kulkov bought out the other investors, then took the company private again in 2016. He and Kulkov also built stakes in other drug companies, including OTCPharm, Biocad, and Generium. Outside medicine, he became co-owner of the Nürburgring in Germany in October 2014, adding another high-profile asset.

How Viktor Kharitonin built his wealth

Most of Kharitonin's wealth comes from pharmaceuticals. His central business was Pharmstandard, the firm he helped form in 2003 by merging 5 factories with Roman Abramovich and other partners. After the company listed in London, he and Egor Kulkov increased their control by buying out the other investors in 2008. They later brought the company back into private hands in 2016, keeping close control of a business that had already become a major source of wealth.

His money is also tied to stakes in other Russian healthcare companies. Forbes notes holdings in OTCPharm, Biocad, and Generium, which is one of the producers of the COVID-19 vaccine Sputnik V. He has also invested beyond medicine. In October 2014, he became co-owner of the Nürburgring in Germany, one of Europe's oldest race tracks. In 2023, he and his partners bought Russian assets of Henkel for 600 million euros, while Henkel kept a buyback option.

Forbes net worth and major transactions

Forbes has tracked sharp changes in Kharitonin's fortune over time. Its World's Billionaires List estimated him at $1.2 billion in 2019, then $2.3 billion in 2020 and $3.4 billion in 2021. The estimate then fell to $1.4 billion in 2022 before rising to $5 billion in 2023. Those changes came while his wealth remained centered on pharmaceutical holdings and related investments across the healthcare sector.

The climb continued after that. Forbes estimated his fortune at $6.9 billion in 2024 and $7.5 billion in 2025. Forbes' real-time billionaires tracker listed him at $7.9 billion as of October 20, 2026. During this period, he and Kulkov also pursued large deals outside core drug assets. In 2022, they tried to buy Mondi's Russian assets for 1.5 billion euro, but Russian authorities rejected the transaction.